Status:
NOT_YET_RECRUITING
The Effect of a Multi-modal Program on Fear of Cancer Recurrence in Breast Cancer Patients
Lead Sponsor:
LIU WEIMIN
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if MMP intervention can alleviate FCR , breast cancer symptoms and social support among breast cancer patients. he main questions it aims to answer are: * ...
Eligibility Criteria
Inclusion
- Diagnosis meets the criteria outlined in the Breast Cancer Diagnosis and Treatment Guidelines, with a pathological diagnosis of breast cancer and currently undergoing chemotherapy
- Age ≥ 18 years
- Clear consciousness and the ability to communicate independently
- Aware of the diagnosis and has signed the informed consent form
Exclusion
- Presence of mental illness or cognitive impairment
- Hearing or speech impairmen
- Distant metastasis of cance
- Severe physical illness or other malignant tumors requiring treatment
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06883877
Start Date
June 1 2025
End Date
November 30 2025
Last Update
March 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.